Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This is discussed with you in detail during your consultation
Clinical trials extend to 72 weeks and beyond
Our advanced formula penetrates deep into the skin, reducing melanin production and diminishing dark spots and hyperpigmentation
The novel dual GLP-1/GIP receptor agonist DA-CH5 is superior to single GLP-1 receptor agonists in the MPTP model of Parkinson?s disease
HPA-axis regulation The HPA axis is the neuroendocrine stress axis orchestrating the release of the stress hormones such as glucocorticoids
Wound healing activity of carbon monoxide liberated from co-releasing molecule (CO-RM)
US$ 20.06
US$ 20.40
US$ 20.10
US$ 24.56
